# Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

> **NCT04416581** · PHASE4 · RECRUITING · sponsor: **Duk-Woo Park, MD** · enrollment: 3320 (estimated)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Acute Coronary Syndrome
- Myocardial Infarction

## Interventions

- **DRUG:** PPI
- **DRUG:** P-CAB 50

## Key facts

- **NCT ID:** NCT04416581
- **Lead sponsor:** Duk-Woo Park, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-12
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 3320 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04416581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04416581, "Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04416581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*